| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | -0.0053 | 0.9 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | 0.0056 | 0.9 |
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | 0.026 | 0.9 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | 0.0057 | 0.9 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.0064 | 0.9 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | -0.0055 | 0.9 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | 0.0056 | 0.9 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.0057 | 0.9 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.0058 | 0.9 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | 0.0052 | 0.9 |